Insights

Gathering insights about Leuko…

Similar companies to Leuko

Leuko Tech Stack

Leuko uses 3 technology products and services including Google Analytics, Squarespace, Google Font API, and more. Explore Leuko's tech stack below.

Google Analytics
Analytics
Squarespace
Content Management System
Google Font API
Font Scripts

Media & News

National Cancer Institute invests into Leuko Labs Inc. $4.5M.
The National Institutes of Health (NIH) National Cancer Institute has awarded a $4.5 million grant to Leuko to further develop PointCheck, the first solution to enable non-invasive white blood cell monitoring.
Aug 22, 2024 | www.mpo-mag.com
National Institutes of Health invests into Leuko Labs Inc. $4.5M.
Leuko has been awarded a $4.5m grant from the National Institutes of Health (NIH) to advance the development of its non-invasive white blood cell monitoring device, PointCheck.
Jul 24, 2024 | www.medicaldevice-network.com
Leuko Labs Inc. receives award Small Business Innovative Research phase IIB award.
Medtech firm Leuko has received a $4.5 million Small Business Innovative Research phase IIB award from the U.S. National Institutes of Health National Cancer Institute to advance the development of PointCheck, its noninvasive at-home white blood cell monitoring device.
Jul 24, 2024 | www.labpulse.com
Leuko Labs Inc. is developing at-home white blood cell monitor on Jun 16th '24.
Leuko, founded by researchers at the Massachusetts Institute of Technology (MIT), has developed an at-home white blood cell monitor to help doctors non-invasively monitor cancer patients' health during chemotherapy.
Jun 17, 2024 | pharmatimes.com
Leuko Labs Inc. is developing device that allows patients to measure white blood cell levels on Jan 1st '21.
Leuko, a Boston and Madrid-based healthtech startup (and EIT Catapult’s 2021 medtech winner), is developing a device that allows patients to measure their white blood cell levels at home without drawing blood samples.
Apr 24, 2023 | sifted.eu
Leuko Labs Inc. partners with MD Anderson Cancer Center.
Leuko is collaborating with leading cancer centres, including Boston Medical Center and MD Anderson in the USA and Dexeus and Hospital 12 de Octubre in Madrid.
Sep 25, 2022 | www.htworld.co.uk
Leuko Labs Inc. partners with Boston Medical Center.
Leuko is collaborating with leading cancer centres, including Boston Medical Center and MD Anderson in the USA and Dexeus and Hospital 12 de Octubre in Madrid.
Sep 25, 2022 | www.htworld.co.uk

Leuko's Email Address Formats

Leuko uses at least 2 format(s):

Leuko Email Formats	Example	Percentage
First@leuko.io	John@leuko.io	100%

Frequently Asked Questions

Where is Leuko's headquarters located?

Leuko's main headquarters is located at 8 St Marys St Boston, Massachusetts 02215 US. The company has employees across 2 continents, including North AmericaEurope.

What is Leuko's stock symbol?

Leuko is a publicly traded company; the company's stock symbol is LKST.

What is Leuko's official website and social media links?

Leuko's official website is leuko.com and has social profiles on LinkedIn.

How much revenue does Leuko generate?

As of November 2024, Leuko's annual revenue reached $3.8M.

What is Leuko's NAICS code?

Leuko's NAICS code is 3391 - Medical Equipment and Supplies Manufacturing.

How many employees does Leuko have currently?

As of November 2024, Leuko has approximately 16 employees across 2 continents, including North AmericaEurope. Key team members include Chief Data Scientist & Cofounder: A. B.Co-Founder And Ceo: C. C. G.Cofounder | Chief Medical Officer: A. S.. Explore Leuko's employee directory with LeadIQ.

What industry does Leuko belong to?

Leuko operates in the Medical Equipment Manufacturing industry.

What technology does Leuko use?

Leuko's tech stack includes Google AnalyticsSquarespaceGoogle Font API.

What is Leuko's email format?

Leuko's email format typically follows the pattern of . Find more Leuko email formats with LeadIQ.

How much funding has Leuko raised to date?

As of November 2024, Leuko has raised $4.5M in funding. The last funding round occurred on Jul 23, 2024 for $4.5M.

When was Leuko founded?

Leuko was founded in 2017.

Leuko

Medical Equipment ManufacturingMassachusetts, United States11-50 Employees

Leuko is developing the first non-invasive white blood cell device. White blood cell assessment is a first-line indicator for various medically-relevant situations, ranging from chemotherapy management to the detection of life threatening infections worldwide. This test is currently invasive and not readily accessible - it requires patient travel, blood draws and laboratory infrastructure. Based on MIT research, Leuko is re-imagining the way to perform these tests without extracting blood and in a portable device.

Company Overview

Headquarters: 8 St Marys St Boston, Massachusetts 02215 US
Website: leuko.com
Stock Symbol: LKST
NAICS Code: 3391 - Medical Equipment and Supplies Manufacturing
Founded: 2017
Employees: 11-50

Media & News

Funding & Financials

$4.5M
Leuko has raised a total of $4.5M of funding over 9 rounds. Their latest funding round was raised on Jul 23, 2024 in the amount of $4.5M.
$10M
Leuko's revenue is in the range of $10M

Funding & Financials

$4.5M
Leuko has raised a total of $4.5M of funding over 9 rounds. Their latest funding round was raised on Jul 23, 2024 in the amount of $4.5M.
$10M
Leuko's revenue is in the range of $10M

Company Leadership

A. B.
Chief Data Scientist & Cofounder
✕
Access Insights for Leuko and Millions of Other Companies
Sign up for full access to Leuko information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Leuko and Millions of Other Companies
Sign up for full access to Leuko information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
C. C. G.
Co-Founder And Ceo
✕
Access Insights for Leuko and Millions of Other Companies
Sign up for full access to Leuko information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Leuko and Millions of Other Companies
Sign up for full access to Leuko information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
A. S.
Cofounder | Chief Medical Officer
✕
Access Insights for Leuko and Millions of Other Companies
Sign up for full access to Leuko information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Leuko and Millions of Other Companies
Sign up for full access to Leuko information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
I. B.
Cofounder & Cto
✕
Access Insights for Leuko and Millions of Other Companies
Sign up for full access to Leuko information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Leuko and Millions of Other Companies
Sign up for full access to Leuko information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
W. S.
Director Of Manufacturing
✕
Access Insights for Leuko and Millions of Other Companies
Sign up for full access to Leuko information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Leuko and Millions of Other Companies
Sign up for full access to Leuko information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email

Employee Directory

G. L.
Senior Human Factors Engineer
✕
Access Insights for Leuko and Millions of Other Companies
Sign up for full access to Leuko information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Leuko and Millions of Other Companies
Sign up for full access to Leuko information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
A. S.
Board Member
✕
Access Insights for Leuko and Millions of Other Companies
Sign up for full access to Leuko information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Leuko and Millions of Other Companies
Sign up for full access to Leuko information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
M. G.
Non Executive Board Member
✕
Access Insights for Leuko and Millions of Other Companies
Sign up for full access to Leuko information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Leuko and Millions of Other Companies
Sign up for full access to Leuko information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
A. P. T.
Deep Learning Engineering
✕
Access Insights for Leuko and Millions of Other Companies
Sign up for full access to Leuko information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Leuko and Millions of Other Companies
Sign up for full access to Leuko information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
A. C.
Engineering Intern
✕
Access Insights for Leuko and Millions of Other Companies
Sign up for full access to Leuko information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Leuko and Millions of Other Companies
Sign up for full access to Leuko information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email

Go to Employee Directory

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

Insights

Similar companies to Leuko

Quartzy

Solenica

Kebotix

Elemental Machines

Leuko Tech Stack

Media & News

National Cancer Institute invests into Leuko Labs Inc. $4.5M.

National Institutes of Health invests into Leuko Labs Inc. $4.5M.

Leuko Labs Inc. receives award Small Business Innovative Research phase IIB award.

Leuko Labs Inc. is developing at-home white blood cell monitor on Jun 16th '24.

Leuko Labs Inc. is developing device that allows patients to measure white blood cell levels on Jan 1st '21.

Leuko Labs Inc. partners with MD Anderson Cancer Center.

Leuko Labs Inc. partners with Boston Medical Center.

Leuko's Email Address Formats

Frequently Asked Questions

Where is Leuko's headquarters located?

What is Leuko's stock symbol?

What is Leuko's official website and social media links?

How much revenue does Leuko generate?

What is Leuko's NAICS code?

How many employees does Leuko have currently?

What industry does Leuko belong to?

What technology does Leuko use?

What is Leuko's email format?

How much funding has Leuko raised to date?

When was Leuko founded?

Leuko

Company Overview

Media & News

National Cancer Institute invests into Leuko Labs Inc. $4.5M.

National Institutes of Health invests into Leuko Labs Inc. $4.5M.

Leuko Labs Inc. receives award Small Business Innovative Research phase IIB award.

Funding & Financials

Funding & Financials

Company Leadership

Employee Directory

Ready to create more pipeline?

Ready to create more pipeline?